Emergent BioSolutions | EBS - Işletme Karı





Işletme Karı Değişiklik Tarih
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD 36.59M 102.52M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 51.84M 12M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Exelixis USD 268.42M 20.01M 2026-09
Glaxosmithkline GBP 2.13B 166M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Lonza CHF 673M 243M 2025-06
Merck USD 7.33B 6.49B 2026-09
Moderna USD 130M 945M 2026-09
Myriad Genetics USD -3M 20.3M 2025-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Pacira USD 2.57B 2.56B 2026-09
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 148.98M 103.09M 2026-06
Sanofi EUR 4.72B 2.34B 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
United Therapeutics USD 241.3M 89.5M 2026-09
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12